Virtus Lifesci Biotech Etf Current Valuation
| BBC Etf | USD 27.56 0.10 0.36% |
Valuation analysis of Virtus LifeSci Biotech helps investors to measure Virtus LifeSci's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Virtus LifeSci's price fluctuation is very steady at this time. Calculation of the real value of Virtus LifeSci Biotech is based on 3 months time horizon. Increasing Virtus LifeSci's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Virtus LifeSci is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Virtus Etf. However, Virtus LifeSci's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.56 | Real 27.85 | Hype 27.56 | Naive 28.98 |
The real value of Virtus Etf, also known as its intrinsic value, is the underlying worth of Virtus LifeSci Biotech ETF, which is reflected in its stock price. It is based on Virtus LifeSci's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Virtus LifeSci's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Virtus LifeSci Biotech helps investors to forecast how Virtus etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Virtus LifeSci more accurately as focusing exclusively on Virtus LifeSci's fundamentals will not take into account other important factors: Virtus LifeSci Biotech ETF Current Valuation Analysis
Virtus LifeSci's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Virtus LifeSci Biotech has a Current Valuation of 0.0. This indicator is about the same for the Virtus average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Fund Asset Allocation for Virtus LifeSci
The fund consists of 98.9% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides Virtus LifeSci's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Virtus Fundamentals
| Price To Earning | 39.87 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 1.99 X | |||
| Number Of Employees | 347 | |||
| Beta | 0.99 | |||
| Total Asset | 18.12 M | |||
| One Year Return | 40.50 % | |||
| Three Year Return | (12.10) % | |||
| Five Year Return | (3.00) % | |||
| Net Asset | 18.12 M | |||
| Equity Positions Weight | 98.90 % |
About Virtus LifeSci Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virtus LifeSci Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virtus LifeSci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virtus LifeSci Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:Check out Virtus LifeSci Piotroski F Score and Virtus LifeSci Altman Z Score analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.